Tag: Biofourmis
Biofourmis Raises $100 Million In Series C Funding To Accelerate Global Expansion
Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised $100 million Series C financing round led by SoftBank Vision Fund 2, with […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Chugai and Biofourmis Collaborating to Develop Digital Solution For Objective Assessment of Pain
Chugai Pharmaceutical, one of Japan’s leading research-based pharmaceutical companies and Biofourmis, a Boston-based digital therapeutics company, announced that they have partnered to develop a digital solution for the objective assessment […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Biofourmis’ AI-Powered Tech Being Used in Remote Monitoring of COVID-19 Patients in Hong Kong
Biofourmis, a developer of digital therapeutics that powers personalized predictive care, announced that its technology is being leveraged in a remote monitoring and disease surveillance program in Hong Kong involving […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Biofourmis Collaborates with ImagineMIC to Improve Remote Patient Monitoring for Chronic Disease Patients
Biofourmis, a fast-growing global health IT start-up founded in Singapore, and ImagineMIC, a New York-based medical device company formed a partnership to drive improved outcomes and lower healthcare costs for […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Biofourmis Buys Biovotion to Deliver Precise Interventions for Patients with Complex Chronic Conditions
US-based digital therapeutics company Biofourmis has signed an agreement to buy Zurich, Switzerland-based wearable biosensor company Biovotion. The deal consists of all Biovotion’s assets, including the clinical-grade Everion® device and […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Biofourmis to Partner with Yale University-Mayo Clinic Collaborative Program CERSI
Biofourmis, a global leader in digital therapeutics, has entered a research partnership with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). The study, which involves patients […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).